Fundz

Oncodesign Precision Medicine Announces A 6 Million Euros Bank Financing From Caisse D’Épargne Bourgogne Franche Comté, Crédit Agricole De Champagne Bourgogne And Société Générale

PRIVATEOct 05, 2023

Round Type

Funding Round

DijonBiotechnologyHealth Care

Investors

P.C.G.BpifranceSociété GénéraleCrédit Agricole Champagne BourgogneCaisse D'épargne Bourgogne Franche Comté

Description

Regulatory News:

Quick answer

Oncodesign Precision Medicine raised an undisclosed amount in a Funding Round round, dated October 5, 2023. Investors: P.C.G., Bpifrance, Société Générale, Crédit Agricole Champagne Bourgogne and Caisse D'épargne Bourgogne Franche Comté. Oncodesign Precision Medicine is based in Dijon, Bourgogne – Franche-Comté, France.

How much did Oncodesign Precision Medicine raise?
Oncodesign Precision Medicine raised an undisclosed amount in a Funding Round round on October 5, 2023.
Who invested in Oncodesign Precision Medicine?
P.C.G., Bpifrance, Société Générale, Crédit Agricole Champagne Bourgogne and Caisse D'épargne Bourgogne Franche Comté are named as investors in this round.
What does Oncodesign Precision Medicine do?
Oncodesign Precision Medicine (OPM) is a biopharmaceutical company specializing in precision medicine for the treatment of resistant and metastatic cancers.
Where is Oncodesign Precision Medicine based and how big is it?
Oncodesign Precision Medicine is based in Dijon, Bourgogne – Franche-Comté, France. Fundz records about 18 employees.
Who are the decision-makers at Oncodesign Precision Medicine?
Fundz holds 1 contact at Oncodesign Precision Medicine. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at Oncodesign Precision Medicine, and when

A new round usually means Oncodesign Precision Medicine is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Oncodesign Precision Medicine raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Oncodesign Precision Medicine, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Oncodesign Precision Medicine. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Oncodesign Precision Medicine

Location

Dijon, Bourgogne – Franche-Comté, France

About

Oncodesign Precision Medicine (OPM) is a biopharmaceutical company specializing in precision medicine for the treatment of resistant and metastatic cancers.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Oncodesign Precision Medicine raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Oncodesign Precision Medicine's next move

See what Strategic adds

Oncodesign Precision Medicine raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.